Welcome to Library
Annual Reports
RMRIMS News Bulletine
 
Publications List of Dr. Pradeep Das
 

214.

Lal CS, Verma RB, Verma N, Siddiqui NA, Rabidas VN, Pandey K, Singh D, Kumar S, Paswan RK, Kumari A, Sinha P and Das P. Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis. Infection. 2016; 44(1): 39-45. doi: 10.1007/s15010-015-0811-9. (Epub 2015 Jul 10).

213.

Suman SS, Equbal A, Zaidi A, Ansari MY, Singh KP, Singh K, Purkait B, Sahoo GC, Bimal S, Das P and Ali V. Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase. Biochimie. 2016; 121: 312-325. doi: 10.1016/j.biochi.2015.12.017. (Epub 2015 Dec 30).

212.

Vijayamahantesh, Amit A, Kumar S, Dikhit MR, Jha PK, Singh AK, Sinha KK, Pandey K, Das VN, Das P and Bimal S. Up regulation of A2B adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to Leishmania donovani. Cytokine. 2016; 79: 38-44. doi: 10.1016/j.cyto.2015.12.016. (Epub 2015 Dec 31).

211.

Kumar R, Sahoo GC, Pandey K, Das VN, Topno RK, Ansari MY, Rana S and Das P. Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis. Mater Sci Eng C Mater Biol Appl. 2016; 59: 748-573. doi: 10.1016/j.msec.2015.10.083. (Epub 2015 Oct 29).

210.

Kumar R, Sahoo GC, Pandey K, Das V, Das P. Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani. Drug Deliv. 2015; 22(3): 383-388. doi: 10.3109/10717544.2014.891271. (Epub 2014 Mar 6).

209.

Zaidi A, Singh KP, Anwar S, Suman SS, Equbal A, Singh K, Dikhit MR, Bimal S, Pandey K, Das P and Ali V. Interaction of frataxin, an iron binding protein, with IscU of Fe-S clusters biogenesis pathway and its upregulation in AmpB resistant Leishmania donovani. Biochimie. 2015; 115: 120-135. doi: 10.1016/j.biochi.2015.05.016. (Epub 2015 May 30).

208.

Rama A, Kumar V, Kesari S, Singh VP and Das P. Monitoring Susceptibility Status of Phlebotomus argentipes (Diptera: Psychodidae) at Bihar (India) for the Procurement of Homozygous DDT Resistant ColonyJ Trop Dis. 2015; 3:4. doi: 10.4172/ 2329891X. 1000170. http://dx.doi.org/10.4172/2329-891X.1000170

 

207.

Moharana KC, Dikhit MR, Sahoo BR, Sahoo GC and Das PGAOPP: Operon Prediction in Prokaryotes Using Genetic Algorithm. Current Bioinformatics, 2015; 10(3): 299-305.

 

206.

Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD, Lima MA, Mitra G, Kumar D, Pandey K, Van Geertruyden JP, Boelaert M and Burza S. Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India. Clin Infect Dis. 2015; 61(8): 1255-1262. doi: 10.1093/cid/civ530. (Epub 2015 Jun 30).

205.

Kumar V, Shankar L, Rama A, Kesari S, Dinesh DS, Bhunia GS and Das P. Analyzing host preference behavior of Phlebotomus argentipes (Diptera:Psychodidae) under the Impact of Indoor Residual Spray. International Journal of Tropical Disease & Health. 2015; 7(2): 69-79.

 

204.

Kumar V, Shankar L, Kesari S, Bhunia GS, Dinesh DS, Mandal R and Das P. Insecticide susceptibility of Phlebotomus argentipes & assessment of vector control in two districts of West Bengal, India. Indian J Med Res. 2015; 142(2): 211-215. doi: 10.4103/0971-5916.164260.

203.

Hassan F, Dinesh DS, Purkait B, Kumari S, Kumar V and Das P. Bio-Chemical Characterization of detoxifying enzymes in DDT resistant field isolates of Phlebotomus argentipes in Bihar, India. International Journal of Medicine and Pharmaceutical Sciences (IJMPS).2015; 5(2): 23-32.

 

202.

Dikhit MR, Kumar S, Vijaymahantesh, Sahoo BR, Mansuri R, Amit A, Ansari MY, Sahoo GC, Bimal S and Das P. Computational elucidation of potential antigenic CTL epitopes in Ebola virus. Infecttion, Genetics and Evolution. 2015; 36: 369-375.

 

201.

Das S, Ghosh AK, Singh S, Saha B, Ganguly A and Das P. Unmethylated CpG motifs in the L. donovani DNA regulate TLR9-dependent delay of programmed cell death in macrophages. J Leukoc Biol. 2015; 97(2): 363-378. doi: 10.1189/jlb.4A0713-378RR. (Epub 2014 Dec 3).

200.

Coleman M, Foster GM, Deb R, Pratap Singh R, Ismail HM, Shivam P, Ghosh AK, Dunkley S, Kumar V, Coleman M, Hemingway J, Paine MJ and Das P. DDT-based indoor residual spraying suboptimal for visceral leishmaniasis elimination in India. Proc Natl Acad Sci U S A. 2015; 112(28): 8573-8578. doi: 10.1073/pnas.1507782112. (Epub 2015 Jun 29).

199.

Banjara MR, Kroeger A, Huda MM, Kumar V, Gurung CK, Das ML, Rijal S, Das P and Mondal D. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study. Trans R Soc Trop Med Hyg. 2015; 109(6): 408-15. doi: 10.1093/trstmh/trv031. (Epub 2015 Apr 26).

198.

Ansari MY, Equbal A, Dikhit MR, Mansuri R, Rana S, Ali V, Sahoo GC and Das P. Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors. Int J Biol Macromol. 2015; 83: 78-96. doi: 10.1016/j.ijbiomac.2015.11.051.

197.

Verma N, Bimal S, Das VNR, Pandey K, Singh D, Lal CS, Singh AS, Sinha PK and Das P. Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study. BioMed Research International 2015; Article ID 745062. http://dx.doi.org/10.1155/2015/745062

 

196.

Thakur AK, Pushpanjali, Narayan S, Bimal S, Singh SK, Gupta AK and Das P. An approach to hemoglobin recycling through Leishmania infected macrophage and its impact on visceral leishmaniasis. International Journal of Advanced Research 2015; 3(2): 868-877.

 

195.

Ghosh AK, Sardar AH, Mandal A, Saini S, Abhishek K, Kumar A, Purkait B, Singh R, Das S, Mukhopadhyay R, Roy S and Das P. Metabolic reconfiguration of the central glucose metabolism: A crucial strategy of Leishmania donovani for its survival during oxidative stress. FASEB J. 2015; 29(5): 2081-2098. doi: 10.1096/fj.14-258624. (Epub 2015 Feb 17).

194.

Kumari S, Jamal F, Shivam P, Thakur A, Kumar M, Bimal S, Das VN, Pandey K, Narayan S, Gupta AK, Das P and Singh SK. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis. Cytokine. 2015; 73(1): 53-60. doi: 10.1016/j.cyto.2015.01.011. (Epub 2015 Feb 16).

193.

Purkait B, Singh R, Wasnik K, Das S, Kumar A, Paine M, Dikhit M, Singh D, Sardar AH, Ghosh AK and Das P. Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani. J Antimicrob Chemother. 2015; 70(5): 1343-1356. doi: 10.1093/jac/dku534. (Epub 2015 Feb 8).

192.

Yadav A, Amit A, Chaudhary R, Chandel AS, Mahantesh V, Suman SS, Singh SK, Dikhit MR, Ali V, Rabidas V, Pandey K, Kumar A, Das P and Bimal S. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. Int J Parasitol. 2015; 45(1): 33-42. doi: 10.1016/j.ijpara.2014.08.013. (Epub 2014 Oct 15).

191.

Das P, Amit A, Singh SK, Chaudhary R, Dikhit MR, Yadav A, Pandey K, Das VN, Sundram S, Das P and Bimal S. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis. Parasitol Int. 2015; 64(1): 18-25. doi: 10.1016/j.parint.2014.08.004. (Epub 2014 Sep 16).

190.

Sethi MK, Khan MA, Murti K, Singh D, Das P and Pandey K. Coinfection Neurocysticercosis and Intracranial Tuberculoma : a rare case. International Journal of Pharmaceutical Science and Health Care, 2014; 4(3): 148-154.

 

189.

Sahoo G, Rana S, Dikhit MR, Ansari MY and Das P. Computational analysis of microarray gene expression profiling in Leishmania donovani and Leishmania major. Research & Review: A journal of Bioinformatics, 2014, 1(1).

 

188.

Rama A, Kumar V, Kesari S, Diensh DS and Das P. Exploring semiochemical based oviposition response of Phlebotomus argenitipes (Diptera: Psychodidae) towards pre-existing colony ingredients. IJMPS, 2014; 4(4): 35-46.

 

187.

Pandey K, Singh D, Bimal S, Murti K and Das P. Association of testosterone and cholesterol level in modulation of immunity and severity of disease in visceral leishmaniasis patients – a preliminary study. American Journal of Immunology, 2014; 10(1): 46-55.

 

186.

Pandey K, Singh D, Bimal S, Rabidas V, Murti K, Lal CS and Das P. Newer drugs for Visceral Leishmaniasis: a review. American Journal of Infectious Diseases, 2014; 10 (2): 68-70.

 

185.

Kumari S, Hassan F, Kumar V, Kumar J, Pandit V, Rama A, Kumari N, Das P and Dinesh DS. Evaluation of toxic effect of plant extracts having insecticidal effect to sandfly. Elixir Appl Botany, 2014; 75: 27845-27848.

 

184.

Sahoo GC, Yousuf Ansari M, Dikhit MR, Kannan M, Rana S and Das P. Structure prediction of gBP21 protein of L. donovani and its molecular interaction.  J Biomol Struct Dyn. 2014; 32(5): 709-729. doi: 10.1080/07391102.2013.789400. (Epub 2013 Jun 8).

183.

Dinesh DS, Kumar V and Das P. Infestation of nematodes in Phlebotomus argenitpes Annandale and Brunetti (Diptera: Psycodidae), Bihar, India. Global J Med Res Dis., 2013; 13(6): 7-9.

 

182.

Dikhit MR, Moharana KC, Sahoo BR, Sahoo GC and Das P. LeishMicrosatDB: open source database of repeat sequences detected in six fully sequenced Leishmania genomes. Database, 2014; 10.1093/database/bau078 (http://biomedinformri.com/leishmicrosat).

 

181.

Das S, Matlashewski G, Bhunia GS, Kesari S, Das P. Asymptomatic Leishmania infections in northern India: a threat for the elimination programme? Trans R Soc Trop Med Hyg. 2014; 108(11): 679-684. doi: 10.1093/trstmh/tru146. (Epub 2014 Sep 9).

180.

Anwar S, Dikhit MR, Singh KP, Kar RK, Zaidi A, Sahoo GC, Roy AK, Nozaki T, Das P and Ali V. Interaction between Nbp35 and Cfd1 Proteins of Cytosolic Fe-S Cluster Assembly Reveals a Stable Complex Formation in Entamoeba histolytica. PLoS One. 2014; 9(10):e108971. doi: 10.1371/journal.pone.0108971.

 

179.

Equbal A, Suman SS, Anwar S, Singh KP, Zaidi A, Sardar AH, Das P and Ali V. Stage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovani. PLoS One. 2014; 9(6): e97600. doi: 10.1371/journal.pone.0097600

 

178.

Sethi MK, Singh D, Murti K, Chaudhaery SS, Pandey K and Das P. DPP-4 inhibitors: A novel approach for management of type-2 diabetes mellitus. World J Pharm Sci. 2014; 2(10): 1395-1400.

 

177.

Burza S, Mahajan R, Sinha PK, van Griensven J, Pandey K, Lima MA, Sanz MG, Sunyoto T, Kumar S, Mitra G, Kumar R, Verma N and Das P. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome). PLoS Negl Trop Dis. 2014; 8(8): e3053. doi: 10.1371/journal.pntd.0003053.

176.

Sundar S, Pandey K, Thakur CP, Jha TK, Das VN, Verma N, Lal CS, Verma D, Alam S and Das P. Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study. PLoS Negl Trop Dis. 2014; 8(9): e3169. doi: 10.1371/journal.pntd.0003169.

175.

Pratap Singh K, Zaidi A, Anwar S, Bimal S, Das P and Ali V. Reactive oxygen species regulates expression of iron-sulfur cluster assembly protein IscS of Leishmania donovani. Free Radic Biol Med. 2014; 75C: 195-209

174.

Khan MA, Murti K, Grover V, Lal K, Singh D, Das P and Pandey K. Atorvastatin Vs rosuvastatin; Fenofibrate as an add on: An exploratory study.   Int J Pharm Pharm Sci, 2014; 6(8): 493-498.

 

173.

Kumar A, Das S, Purkait B, Sardar AH, Ghosh AK, Dikshit MR, Abhishek K and Das P. Ascorbate Peroxidase: a key molecule regulating the Amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother. 2014 Aug 11. pii: AAC.02834-14. [Epub ahead of print]

172.

Sahoo GC, Ansari MY, Rana SP, Dikhit MR, Topno RK, Pandey K and Das P. Molecular Modeling and Ligand-Protein Interaction of N-Protein of Chandipura Virus. Letters in Drug Design & Discovery. 2014; 11(2): 211-221.

 

171.

Negi H, Sarkar M, Raval AD, Pandey K and Das P. Presence of depression & its risk factors in patients with chronic obstructive pulmonary disease. Indian J Med Res. 2014; 139(3): 402-408.

170.

Kesari S, Mandal R, Bhunia GS, Kumar V and Das P. Spatial distribution of P. argentipes in association with agricultural surrounding environment in North Bihar, India. J Infect Dev Ctries. 2014; 8(3): 358-364. doi: 10.3855/jidc.3353.

169.

Dinesh DS, Kumar V, Kesari S and Das P. Mites and spiders act as biological control agent to sand flies. Asian Pac J Trop Dis. 2014; 4(Suppl 1): S463-S466.

 

168.

Das VNR, Singh D, Murti K, Das S, Das P and Pandey K. Post Kala-azar Dermal Leishmaniasis with ulceration on foot: An atypical case presentation successfully treated with miltefosine. American Journal of Infectious Diseases, 2014; 10(2): 50-55.

 

167.

Das S, Freier A, Boussoffara T, Das S, Oswald D, Losch FO, Selka M, Sacerdoti-Sierra N, Schönian G, Wiesmüller KH, Seifert K, Schroff M, Juhls C, Jaffe CL, Roy S, Das P, Louzir H, Croft SL, Modabber F and Walden P. Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med. 2014; 6(234): 234ra56. doi: 10.1126/scitranslmed.3008222.

166.

Das S, Halder A, Rabidas VN, Mandal A and Das P. Specific noninvasive detection of Leishmania donovani in desquamated buccal cell swab samples from human visceral Leishmaniasis-HIV coinfected patients. J Clin Microbiol. 2014; 52(4): 1238-1241. doi: 10.1128/JCM.02819-13.

165.

Pandey K, Singh D and Das P. Lipodystrophy in an Immuno-compromised Indian Patient with Pulmonary Tuberculosis and Brain Tuberculoma. Indian Journal of Allied Research. 2014; 4 (6): 390-391.

 

164.

Dinesh DS, Kumari S, Kumar V and Das P. The potentiality of botanicals and their products as an alternative to chemical insecticides to sandflies (Diptera: Psychodidae): a review. J Vector Borne Dis. 2014; 51(1): 1-7.

163.

Das VN, Pandey RN, Pandey K, Singh V, Kumar V, Matlashewski G and Das P. Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India. PLoS Negl Trop Dis. 2014; 8 (5): e2774.

162.

Amit A, Chaudhary R, Yadav A, Suman SS, Narayan S, Das VN, Pandey K, Singh SK, Singh BK, Ali V, Das P and Bimal S. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis. Cell Immunol. 2014; 289(1-2): 76-85. doi: 10.1016/j.cellimm.2014.03.011.

161.

Negi H, Sarkar M, Raval AD, Pandey K and Das P. Health-related quality of life in patients with chronic obstructive pulmonary disease in North India. J Postgrad Med. 2014; 60(1): 7-11. doi: 10.4103/0022-3859.128797.

160.

Das S, Rani M, Rabidas V, Pandey K, Sahoo GC and Das P. TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin–miltefosine combination therapy in visceral leishmaniasis. British Journal of Pharmacology. 2014; 171: 1260–1274.

 

159.

Chaudhary R, Amit A, Yadav A, Singh A, Kumar V, Singh SK, Narayan S, Rabidas V, Pandey K, Kumar A, Das P and Bimal S. Immunomodulation in Human Dendritic Cells Leads to Induction of Interferon-Gamma Production by Leishmania donovani Derived KMP-11 Antigen via Activation of NF-κB in Indian Kala-Azar Patients. Biomed Res Int. 2014; 2014: 947606. doi: 10.1155/2014/947606.

158.

Kumar V, Bimal S, Singh SK, Chaudhary R, Das S, Lal C, Pandey K, Das VR and Das P. Leishmania donovani: Dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis. Nutrition. 2014; 30(4): 449-458.

157.

Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, Verma N, Balsegaram M, and Das P. Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India. Negl Trop PLoS Dis. 2014; 8(1): e2611. doi: 10.1371/journal.pntd.0002611.

156.

Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, Verma N, Balasegarem M and Das P. Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India. PLoS Negl Trop Dis. 2014; 8(1): e2603. doi: 10.1371/journal.pntd.0002603.

155.

Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, Verma N, Balsegaram M, and Das P. Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India. PLoS Negl Trop Dis. 2014; 8(1): e2536. doi: 10.1371/journal.pntd.0002536.

154.

Sahoo GC, Yousuf Ansari M, Dikhit MR, Kannan M, Rana S and Das P. Structure prediction of gBP21 protein of L. donovani and its molecular interaction.  J Biomol Struct Dyn. 2013; http://dx.doi.org/10.1080/07391102.2013.789400

153.

Pandey K, Singh D, Das VR, Bimal S, Singh BK and Das P. Progressive Multifocal Leukoencephalopathy Associated with Pulmonary Tuberculosis in an Immuno-Compromised Indian Patient. J AIDS Clin Res. 2013; 4: 9. http://dx.doi.org/10.4172/2155-6113.1000241.

 

152.

Kumar V, Rama A, Kesari S, Bhunia GS, Singh DS, and Das P. Oviposition behaviour of Phlebotomus argentipes – A laboratory-based study. Mem Inst Oswaldo Cruz. 2013; 108(8): 1065-1067.

151.

Verma N, Singh D, Pandey K, Das VN, Lal CS, Verma RB, Sinha PK and Das P. Comparative Evaluation of PCR and Imprint Smear Microscopy of Skin Biopsy in Diagnosis of Macular, Papular and Mixed Papulo-nodular Lesions of PKDL. J Clin Microbiol. 2013; 51(12): 4217-4219. doi: 10.1128/JCM.01482-13. (Epub 2013 Sep 25).

150.

Shivam P, Jamal F, Kumari S, Bimal S, Narayan S, Das VN, Pandey K, Gupta AK, Singh D, Verma N, Das P and Singh SK. Leishmania donovani: Influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. Hum Immunol. 2013; 74(12): 1575-1578. doi: 10.1016/j.humimm.2013.08.007. (Epub 2013 Aug 20).

149.

Pandey K, Singh D, Lal C S, Das V, Das P. Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment. J Postgrad Med. 2013; 59(4): 306-308. doi: 10.4103/0022-3859.123161.

148.

Sardar AH, Das S, Agnihorti S, Kumar M, Ghosh AK, Abhishek K, Kumar A, Purkait B, Ansari MY and  Das P. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani. Exp Parasitol. 2013; 135(4): 715-725. doi: 10.1016/j.exppara.2013.10.011.        (Epub 2013 Nov 1).

147.

Naznin E, Kroeger A, Siddiqui NA, Sundar S, Malaviya P, Mondal D, Huda MM, Das P, Karki P, Banjara MR, Dreesch N and Gedik G. Human resource assessment for scaling up VL active case detection in Bangladesh, India and Nepal. Trop Med Int Health. 2013; 18(6): 734-742. doi: 10.1111/tmi.12124. (Epub 2013 May 8).

146.

Das S, Pandey K, Rabidas VN, Mandal A and Das P. Effectiveness of miltefosine treatment in targeting anti-leishmanial HO-1/Nrf-2-mediated oxidative responses in visceral leishmaniasis patients. J Antimicrob Chemother. 2013; 68(9): 2059-2065. doi: 10.1093/jac/dkt162. (Epub 2013 May 31).

145.

Thakur AK, Bimal S, Singh SK, Gupta AK, Das VN, Das P and Narayan S. Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis. Exp Parasitol. 2013; 135(3): 595-598. doi: 10.1016/j.exppara.2013.09.008.

144.

Matlashewski G, Pandey R, Das V and Das P. One More Death from Visceral Leishmaniasis Has Gone by Unnoticed. What Can Be Done? PLoS Negl Trop Dis. 2013; 27: 7(6): e2082.

143.

Matlashewski G, Das VN, Pandey K, Singh D, Das S, Ghosh AK, Pandey RN and Das P. Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum. PLoS Negl Trop Dis. 2013; 23: 7(5): e2233.

142.

Kumar V, Kesari S, Chowdhury R, Kumar S, Sinha G, Hussain S, Huda MM, Kroeger A and Das P. User friendliness, efficiency & spray quality of stirrup pumps versus hand compression pumps for indoor residual spraying. Indian J Med Res. 2013; 138(2): 239-243.

141.

Verma N, Lal CS, Rabidas V, Pandey K, Singh D, Kumar S, Verma RB and Das P. Microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis. Biomed Res Int. 2013; 2013: 498918. doi: 10.1155/2013/498918. (Epub 2013 Jun 23).

140.

Das V, Pandey K, Singh D, Forwood C, Lal CS and Das P. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India. J Postgrad Med. 2013; 59(3): 226-228. doi: 10.4103/0022-3859.118046.

139.

Kar RK, Suryadevara P, Sahoo BR, Sahoo GC, Dikhit MR and Das P. Exploring novel KDR inhibitors based on pharmaco-informatics methodology. SAR QSAR Environ Res. 2013; 24(3): 215-234. doi: 10.1080/1062936X.2013.765912. (Epub 2013 Feb 25).

138.

Kar RK, Suryadevara P, Sahoo BR, Sahoo GC, Dikhit MR and Das P. Exploring novel KDR inhibitors based on pharmaco-informatics methodology. SAR QSAR Environ Res. 2013; 24(3): 215-234. doi: 10.1080/1062936X.2013.765912. (Epub 2013 Feb 25).

137.

Sahoo GC, Dikhit MR, Rani M, Ansari MY, Jha C, Rana S and Das P. Analysis of sequence, structure of GAPDH of Leishmania donovani and its interactions. J Biomol Struct Dyn. 2013; 31(3): 258-75. doi: 10.1080/07391102.2012.698189. (Epub 2012 Jul 25).

136.

Lal CS, Kumar S, Ranjan A, Rabidas VN, Verma N, Pandey K, Verma RB, Das S, Singh D and Das P. Comparative analysis of serum zinc, copper, magnesium, calcium and iron level in acute and chronic patients of visceral leishmaniasis. J Trace Elem Med Biol. 2013; 27(2): 98-102. doi: 10.1016/j.jtemb.2012.09.007. (Epub 2012 Nov 28).

135.

Singh D, Pandey K, Das VN, Das S, Verma N, Ranjan A, Lal CS, Topno KR, Singh SK, Verma RB, Kumar A, Sardar AH, Purkait B and Das P. Evaluation of rK-39 Strip Test Using Urine for Diagnosis of Visceral Leishmaniasis in an Endemic Region of India.  Am Am J Trop Med Hyg. 2013; 88(2): 222-226. doi: 10.4269/ajtmh.2012.12-0489. (Epub 2012 Nov 13).

134.

Sardar AH, Kumar S, Kumar A, Purkait B, Das S, Sen A, Kumar M, Sinha KK, Singh D, Equbal A, Ali V and Das P. Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses. J Proteomics, 2013; 81: 185-199. doi: 10.1016/j.jprot.2013.01.011. (Epub 2013 Jan 30).

133.

Kesari S, Bhunia GS, Chatterjee N, Kumar V, Mandal R and Das P. Appraisal of Phlebotomus argentipes habitat suitability using a remotely sensed index in the kala-azar endemic focus of Bihar, India. Mem Inst Oswaldo Cruz. 2013; 108(2): 197-204.

132.

Bhunia GS, Kesari S, Chatterjee N, Kumar V and Das P. Spatial and temporal variation and hotspot detection of kala-azar disease in Vaishali district (Bihar), India. BMC Infect Dis. 2013; 13: 64. (doi: 10.1186/1471-2334-13-64).

131.

Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, Pandey K, Narain MK, Verma N, Das VN, Das P, Berman J and Arana B. Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial. Trop Med Int Health. 2013; 18(1): 96-100. doi: 10.1111/tmi.12015. ( Epub 2012 Nov 8).

130.

Kumar S, Banerjee R, Nandi N, Sardar AH and Das P. Anoikis potential of Entameba histolytica secretory cysteine proteases: Evidence of contact independent host cell death. Microb Pathog. 2012; 52(1): 69-76. doi: 10.1016/j.micpath.2011.10.005. (Epub 2011 Oct 20).

129.

Das S, Pandey K, Kumar A, Sardar AH, Purkait B, Kumar M, Kumar S, Ravidas VN, Roy S, Singh D and Das P. TGF-β(1) re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20. Immunol Cell Biol. 2012; 90(6): 640-654. doi: 10.1038/icb.2011.80. ( Epub 2011 Oct 4).

128.

Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, Pandey K, Ravidas V, Kumar M, De T, Singh D and Das P. Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani. Antimicrob Agents Chemother. 2012; 56(2): 1031-1041. doi: 10.1128/AAC.00030-11. (Epub 2011 Nov 28).

127.

Bhunia GS, Kesari S, Chatterjee N, Kumar V and Das P. The burden of visceral leishmaniasis in India: Challenges in using Remote Sensing and GIS to understand and control. ISRN Infectious Diseases 2013 (2013), Article ID 675846, (http://dx.doi.org/10.5402/2013/675846).

126.

Sahoo GC, Rani M, Ansari Y, Jha C, Rana S, Dikhit MR, Moharana K, Kumar R and Das P. Structure, Evolution and Virtual Screening of NDM-1 Strain from Kolkata. International Journal of Bioinformatics Research and Applications, 07/2012.

125.

Gupta AK, Narayan S, Singh SK, Thakur AK and Das P. Agar barrier method for removal of yeast and other fungal contamination from Leishmania promastigotes culture. Pathog Glob Health. 2012; 106(7): 418-420. (Doi: 10.1179/2047773212Y.0000000034).

124.

Cunningham J, Hasker E, Das P, El Safi S, Goto H, Mondal D, Mbuchi M, Mukhtar M, Rabello A, Rijal S, Sundar S, Wasunna M, Adams E, Menten J, Peeling R, Boelaert M; for the WHO/TDR Visceral Leishmaniasis Laboratory Network.  A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis.  Clin Infect Dis. 2012; 55(10): 1312-1319. (Epub 2012 Aug 31).

123.

Gupta AK, Narayan S, Verma N, Thakur AK, Das P. Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases: An experimental evidence. J Vector Borne Dis. 2012; 49(4): 266-267.

122.

Bhunia GS, Kesari S, Chatterjee N, Mandal R, Kumar V and Das P. Seasonal relationship between normalized difference vegetation index and abundance of the Phlebotomus kala-azar vector in an endemic focus in Bihar, India. Geospat Health. 2012; 7(1): 51-62.

121.

Kumar V, Krishnakumari B, Kesari S, Kumari K, Kumar R, Ranjan A and Das P. Preliminary observations on the female bahavior of the Indian sandfly vector, Phlebotomus argentipes (Diptera: Psychodidae). Ann. Entomol. Soc. Am. 2012; 105(2): 201-205.

120.

Das S, Rani M, Pandey K, Sahoo GC, Rabidas VN, Singh D and Das P. Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro. J Antimicrob Chemother. 2012; 67(10): 2373-2378. (Epub 2012 Jul 3).

119.

Rana S, Dikhit MR, Rani M, Moharana KC, Sahoo GC and Das P. CPDB: cysteine protease annotation database in Leishmania species. Integr Biol (Camb). 2012; 4(11): 1351-1357. ( doi: 10.1039/c2ib20131c.)

118.

Tehare RA, Sahoo GC and Das P. Homology Modeling, Evaluation and Ligand-protein Interaction of Transcription Initiation Factor Like Protein of Leishmania donovani. International Journal of Drug Design and Discovery, 2012; 3(1): 694-701.

117.

Bhunia GS, Kesari S, Chatterjee N, Kumar V and Das P. Telehealth: a perspective approach for visceral leishmaniasis (kala-azar) control in India. Pathogens and Global Health, 2012; 106(3): 150-158. (doi: 10.1179/2047773212Y.0000000014).

116.

Kar RK, Suryadevara P, Roushan R, Sahoo GC, Dikhit MR and Das P. Quantifying The Structural Requirements for Designing Newer FLT3 Inhibitors. Med Chem. 2012; 8(5): 913-927.

115.

Bhunia GS, Chatterjee N,  Kumar V, Siddiqui NA, Mandal R, Das P and Kesari S. Delimitation of kala-azar risk areas in the district of Vaishali in Bihar (India) using a geo-environmental approach. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2012; 107(5): 609-620.

114.

Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A and Mondal D. Visceral Leishmaniasis clinical management in endemic districts of India, Nepal and Bangladesh. Journal of Tropical Medicine, 2012; 2012: 126093. (Epub 2012 May 9).

113..

Bimal S, Sinha S, Singh SK, Narayan S, Kumar V, Verma N, Ranjan A, Sinha PK, Das VN, Pandey K, Kar SK and Das P. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection. Exp Parasitol. 2012; 131(3): 274-282. (Epub 2012 May 10).

112.

Bhunia GS, Kesari S, Chatterjee N, Kumar V and Das P. Localization of kala-azar in the endemic region of Bihar, India based on land use/land cover assessment at different scales. Geospatial Health. 2012; 6(2): 177-193.

111.

Das VNR, Ranjan A, Pandey K, Singh D, Verma N, Das S, Lal CS, Sinha NK, Verma RB, Siddiqui NA, and Das P. Short Report: Clinico-Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India. Am. J. Trop. Med. Hyg., 2012; 86(6): 959–961.

110.

Ansari MY, Dikhit MR, Sahoo GC and Das P. Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP.  Int J Biol Macromol. 2012; 50(3): 637-649. (Epub 2012 Feb 3).

109.

Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).

108.

Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P and Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet, 2011; 377(9764): 477-486. (Epub 2011 Jan 20).

 

107.

 

Banerjee R, Kumar S, Sen A, Mookherjee A, Roy S, Pal S and Das P. TGF-β-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters.Immunology and Cell Biology, 2011; 89(3): 466-474. (Epub 2010 Sep 21).

106.

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D and Alvar J. Visceral leishmaniasis: elimination with existing interventions. The Lancet Infectious Diseases, 2011; 11(4): 322–325.

105.

Singh SK, Bimal S, Narayan S, Jee C, Bimal D, Das P and Bimal R. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India. Exp Parasitol, 2011; 127(2): 552-558. (Epub 2010 Nov 9).

104.

Bhunia GS, Kesari S, Chatterjee N, Pal DK, Kumar V, Ranjan A and Das P. Incidence of visceral leishmaniasis in the Vaishali district of Bihar, India: spatial patterns and role of inland water bodies. Geospat Health, 2011; 5(2): 205-215.

103.

Ghosh J, Lal CS, Pandey K, Das VN, Das P, Roychoudhury K and Roy S. Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load. Ann Trop Med Parasitol., 2011; 105(3): 267-271.

102.

Kesari S, Bhunia GS, Kumar V, Jeyaram A, Ranjan A and Das P. A comparative evaluation of endemic and non-endemic region of visceral leishmaniasis (Kala-azar) in India with ground survey and space technology. Mem Inst Oswaldo Cruz., 2011; 106(5): 515-523.

101.

Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M and Palma PP. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in bihar, India Clin Infect Dis., 2011; 53(7): e91-e98. (doi:10.1093/cid/cir521)

 

100.

Kumar N, Sinha PK, Pandey K, Verma N, Lal CS, Ranjan A, Verma RB and Das P. A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy. International Journal of Clinical Pharmacy, 2011; Jul 22. [Epub ahead of print].

99.

Das S, Pandey K, Kumar A, Sardar AH, Purkait B, Kumar M, Kumar S, Ravidas VN, Roy S, Singh D and Das P. TGF-β(1) re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20. Immunol Cell Biol, 2011; Oct 4. doi: 10.1038/icb. 2011.80. [Epub ahead of print].

98.

Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N and Das P. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg, 2011; 105(11): 661-666. (Epub 2011 Sep 25).

97.

Chowdhury R, Huda MM, Kumar V, Das P, Joshi AB, Banjara MR, Akhter S, Kroeger A, Krishnakumari B, Petzold M, Mondal D and Das ML. The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: performance and effectiveness. Ann Trop Med Parasitol, 2011; 105(1): 31-45.

96.

Dikhit MR, Nathasharma YP, Patel L, Rana SP, Sahoo GC and Das P. A comparative protein function analysis database of different Leishmania strains. Bioinformation, 2011; 6(1): 20-22.

95.

Huda MM, Mondal D, Kumar V, Das P, Sharma SN, Das ML, Roy L, Gurung CK, Banjara MR, Akhter S, Maheswary NP, Kroeger A and Chowdhury R. Toolkit for monitoring and evaluation of indoor residual spraying for visceral leishmaniasis control in the Indian subcontinent: application and results. Journal of Tropical Medicine, 2011; 2011:876742. (Epub 2011 Jul 27).

94.

Hurwitz I, Hillesland H, Fieck A, Das P and Durvasula R. The paratransgenic sand fly: a platform for control of Leishmania transmission. Parasit Vectors, 2011 May 19; 4:82.

93.

Jayaswal PK, Rani M, Yadav CP, Dikhit MR, Sahoo GC and Das P. Molecular Modeling of Cathepsin B protein in different Leishmania strains. Journal of Integrated OMICS, 2011; 1(1): 115-123.

 

92.

Kumar N, Singh SP, Mondal D, Joshi A, Das P, Sundar S, Kroeger A, Hirve S, Siddiqui NA and Boelaert M. How do health care providers deal with kala-azar in the Indian subcontinent?. Indian J Med Res, 2011; 134(3): 349-55.

91.

Kumar S, Banerjee R, Nandi N, Sardar AH and Das P. Anoikis potential of Entameba histolytica secretory cysteine proteases: Evidence of contact independent host cell death. Microb Pathog, 2011 Oct 20. [Epub ahead of print]

90.

Kumar V, Kesari S, Kumari K, Krishnakumari B, Venugopalan R, Das P. Comparison of In Vivo Host Animals as Blood-Feeding Source for Laboratory Rearing of the Sandfly Vector Phlebotomus argentipes (Diptera: Psychodidae). Annals of the Entomological Society of America, 2011; 104(3): 429-433.

 

89.

Nandi N, Bera T, Kumar S, Purkait B, Kumar A and Das P. Involvement of thermoplasmaquinone-7 in transplasma membrane electron transport of Entamoeba histolytica trophozoites: a key molecule for future rational chemotherapeutic drug designing. J Bioenerg Biomembr, 2011; 43(2): 203-215.

88.

Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, Sundar S, Das P, Gurung CK, Rijal S, Thakur CP, Varghese B and Kroeger A. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis, 2011; 5(2): e960.

87.

Dinesh DS, Kumar AJ, Kumar V, Ranjan A and Das P. Fecundity and life table of different morphotypes of Phlebotomus argentipes (Diptera: Psychodidae). Journal of Parasitic Diseases, 2011; DOI: 10.1007/s12639-011-0035-6.

 

86.

Rani M, Dikhit MR, Sahoo GC and Das P. Comparative domain modeling of human EGF-like module ERM2tudy of interaction of the fourth domain of EGF with chondrotin 4-sulphate. Journal of Biomedical Research, 2011; 25(2): 1-11.

 

85.

Bhunia GS, Dikhit MR, Kesari S, Sahoo GC and Das P. Role of remote sensing, GIS and Bio-informatics in Kala-azar Epidemiology. Journal of Biomedical Research, 2011; 25(6): 1-12.

 

84.

Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, Pandey K, Ravidas V, Kumar M, De T, Singh D and Das P. Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani. Antimicrob Agents Chemother. 2011 Nov 28. [Epub ahead of print]

83.

Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P and Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet, 2011; 377(9764): 477-486. (Epub 2011 Jan 20).

 

82.

Das VNR, Pandey K, Verma N, Bimal S, Lal CS, Singh D and Das P. Post-kala-azar dermal leishmaniasis(PKDL), HIV and pulmonary tuberculosis . National Medical Journal of India. 2010; 23(2): 88-89.

81.

Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VNR, Verma RB and Das P. Awareness about Kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.  Southeast Asian journal of tropical medicine and public health, 2010; 41(1): 1-12.

80.

Sarnoff R, Desai J, Desjeux P, Mittal A, Topno R, Siddiqui NA, Pandey A, Sur D and Das P. Visceral leishmaniasis supplement: the economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India.  Trop Med Int Health. 2010 May 6. [Epub ahead of print]

79.

Clements MF, Gidwani K, Kumar R, Hostomska J, Dinesh DS, Kumar V, Das P, Müller I, Hamilton G, Volfova V, Boelaert M, Das M, Rijal S, Picado A, Volf P, Sundar S, Davies CR and Rogers ME. Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg. 2010; 82(5): 801-807.


78.

Picado A, Das ML, Kumar V, Kesari S, Dinesh DS, Roy L, Rijal S, Das P, Rowland M, Sundar S, Coosemans M, Boelaert M and Davies CR. Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis. 2010; 4(1): e587.


77.

Picado A, Das ML, Kumar V, Dinesh DS, Rijal S, Singh SP, Das P, Coosemans M, Boelaert M and Davies C. Phlebotomus argentipes Seasonal Patterns in India and Nepal. Journal of Medical Entomology, 2010; 47(2):283-286.


76.

Kumar A, Sen A and Das P. Microarray based gene expression: a novel approach for identification and development of potential drug and effective vaccine against visceral Leishmaniasis. International Journal
Advances in Pharmaceutical Sciences
, 2010; 1(1): 01-14.


75.

Das P, Samuels S, Desjeux P, Mittal A, Topno R, Siddiqui NA, Sur D, Pandey A and Sarnoff R. Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India. Tropical Medicine and International Health, 2010; 15(suppl. 2):1-8.

74.

Sarkar S, Banerjee R, Chanda S, Das P, Ganguly S and Pal S. Effectiveness of inoculation with isolated Geobacillus strains in the thermophilic stage of vegetable waste composting. Bioresource Technology, 2010; 101(8): 2892-2895.

73.

Bhunia GS, Kesari S, Jeyaram A, Kumar V and Das P. Influence of topography on the endemicity of Kala-azar: a study based on remote sensing and geographical information system. Geospat Health, 2010; 4(2): 155-165.


72.

Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, Ravidas VN, Kumar N, Pandey K and Das P. Estimation of under reporting of Visceral Leishmaniasis cases in Bihar, India. American Journal of Tropical Medicine Hygiene, 2010; 82(1): 9-11.


71.

Bhunia GS, Kumar V, Kumar AJ, Das P and Kesari S. The use of remote sensing in the identification of the eco–environmental factors associated with the risk of human visceral leishmaniasis (kala-azar) on the Gangetic plain, in north–eastern India. Annals of Tropical Medicine & Parasitology, 2010; 104(1): 35–53.


70.

Mubayi A, Castillo-Chavez C, Chowell G, Kribs-Zaleta C, Ali Siddiqui N, Kumar N and Das P. Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar. Journal of Theoretical Biology, 2010; 262(1): 177-185.


69.

Nandi N, Sen A, Banerjee R, Kumar S, Kumar V, Ghosh AN and Das P. Hydrogen peroxide induces apoptosis-like death in Entamoeba histolytica trophozoites. Microbiology, 2010; 156(Pt 7): 1926-1941.

68.

Kesari S, Bhunia GS, Kumar V, Jeyaram A, Ranjan A and Das P. Study of house-level risk factors associated in the transmission of Indian Kala-azar. Parasit Vectors, 2010; 12: 3: 94.

67.

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R and Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg, 2010; 83(3): 502-506.

66.

Muniaraj M, Sinha PK and Das P. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes. Trop Biomed. 2010; 27(3): 657-661.

65.

Lal CS, Verma N, Rabidas VN, Ranjan A, Pandey K, Verma RB, Singh D, Kumar S and Das P. Total serum cholesterol determination can provide understanding of parasite burden in patients with visceral leishmaniasis infection. Clin Chim Acta. 2010; 411(23-24): 2112-2113. (Epub 2010 Sep 8).

64.

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


63.

Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, Datta S, Raychaudhury B, Naskar K, Haldar AK, Lal CS, Pandey K, Das VN, Das P and Roy S. Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells. Infection and immunity, 2009; 77(6): 2330-2342.


62.

Chatterjee S, Mookerjee A, Basu JM, Chakraborty P, Ganguly A, Adhikary A, Mukhopadhyay D, Ganguli S, Banerjee R, Ashraf M, Biswas J, Das P, Gourisankar Sa, Chatterjee M, Das T and Choudhuri SK. A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells. PloS ONE, 2009; 4(9): e7048.


61.

Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of  mphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.


60.

Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK and Das P. Leishmania donovani vs Immunity: T-cells sensitized from Leishmaniaof one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Experimental Parasitology, 2009; 121: 69-75.


59.

Kumar V, Kesari S, Kumar AJ, Dinesh DS, Ranjan A, Prasad M, Sinha NK, Kumar R and Das P. Vector density and the control of kala-azar in Bihar, India. Mem Inst Oswaldo Cruz, 2009; 104(7): 1019-1022.


58.

Dikhit MR, Rana SP, Das P and Sahoo GC. CHPVDB – a sequence annotation database for Chandipura Virus. Bioinformation, 2009; 3(7): 299-302.


57.

Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, Das P, Kroeger A, Boelaert M and Petzold M. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal. BMC Med, 2009; 7: 54.


56.

Khan AM, Pandey K, Kumar V, Dutta P, Das P and Mahanta J. Sample survey for indigenous cases of kala-azar in Assam by rk39 dipstick test. Indian J Med Res, 2009; 129(3): 327-328.


55.

Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A and Boelaert M. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis, 2009; 3(1): e355.


54.

Singh D, Pandey K, Das VN, Das S, Kumar S, Topno RK and Das P. Novel noninvasive method for diagnosis of visceral leishmaniasis by rK39 testing of sputum samples. J Clin Microbiol, 2009; 47(8): 2684-2685.


53.

Kumar V, Kesari S, Dinesh DS, Tiwari AK, Kumar AJ, Kumar R, Singh VP and Das P. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1). J Vector Borne Dis, 2009; 46(3): 225-229.


52.

Sahoo GC, Dikhit MR, Rani M and Das P. Homology modeling and functional analysis of LPG2 protein of Leishmania strains. J Proteomics Bioinform, 2009; 0: 032-050.

 

51.

Dikhit MR, Sahoo GC and Das P. JEVBase: An interface resource for protein annotation of JE virus. International Journal of Biometrics and Bioinformatics, 2009; 3(4): 59-65.

 

50.

Sahoo GC, Rani M, Dikhit MR, Ansari WA and Das P. Structural modeling, evolution and interaction of KMP11 protein of different Leishmania strains. J Comput Sci Syst Biol, 2009; 2: 147-158.

 

49.

Kumar N, Siddiqui NA, Verma RB and Das P. Knowledge About Sandflies in Relation to Public and Domestic Control Activities of Kala-azar in Rural Endemic Areas of Bihar. Journal of Communicable Diseases, 2009, 41(2): 121-128.

 

48.

Pandey K, Sinha PK, Das VN, Bimal S, Singh SK and Das P. Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario. Clinical Medicine: Pathology, 2009; 2: 1–4.

 

47.

Pandey K, Sinha PK, Das VN, Nawin Kumar, Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


46.

Dinesh DS, Singh A, Kumar V, Kesari S, Kumar AJ, Kishore K, Roy SP, Bhattacharya SK and Das P. Emergence periodicity of Phlebotomus argentipes annandale and brunette (Diptera: psychodidae): A laboratory study. J Parasitic Dis, 2009; 33(1&2): 23-27.

 

45.

Kesari S, Kumar V, Palit A, Kishore K, Das VNR, Das P, and Bhattacharya SK. Localilized Foci of kala-azar in a Village of Chandi PHC (Nalanda District ), Journal of Communucable Diseases, 2009; 41(3) 211-214

 

44.

Bimal S, Singh SK, Sinha S, Pandey K, Sinha PK, Ranjan A, Bhattacharya SK and Das P. Leishmania donovani: Role of CD2 on CD4+ T – cell function in Visceral leishmaniasis. Exp. Parasitol, 2008; 118(2): 238-246.

43.

Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D and Bhattacharya SK. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann. Trop. Med. & Parasitol, (2008); 102(2): 119-125.

42.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Lal CS, Bimal S, Verma N and Das P. HIV infection, visceral leishmaniasis and Guillain –Barre syndrome in same patient: a case report. Ann. Trop. Med. & Parasitol, 2008; 102(2): 185-188.

41.

Dinesh DS, Kumar V, Kesari S, Kumar AJ and Das P. Is Phlebotomus argentipesAnnandale and Brunetti (Diptera: Psychodidae) autogenous?. J Vector Borne Dis, 2008; 45(2): 174-175.


40.

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

39.

Muniaraj M and Das P. Leishmania donovani promastigotes on 'chocolate' agar. Ann Trop Med Parasitol. 2008; 102(5): 451-453.

38.

Dinesh DS, Das P, Picado A, Davies C, Speybroeck N, Ostyn B, Boelaert M and Coosemans M. Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health, 2008; 13(7): 953-958.


37.

Dinesh DS, Das P, Picado A, Davies C, Speybroeck N, Boelaert M and Coosemans M. The efficacy of indoor CDC light traps for collecting the sandfly Phlebotomus argentipes, vector of Leishmania donovani. Med Vet Entomol, 2008; 22(2): 120-123.


36.

Das M, Banjara M, Chowdhury R, Kumar V, Rijal S, Joshi A, Akhter S, Das P and Kroeger A. Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes. Ann Trop Med Parasitol. 2008; 102(8): 729-741.

35.

Hillesland H, Read A, Subhadra B, Hurwitz I, McKelvey R, Ghosh K, Das P and Durvasula R. Identification of aerobic gut bacteria from the Kala azar vector, Phlebotomus argentipes:a platform for potential paratransgenic manipulation of sandflies. American Journal of Tropical medicine and Hygine, 2008; 79(6): 881-886.


34.

Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK and Sinha A. Impact of Ampotericin B in the treatment of Kalaazar on the incidence of PKDL in Bihar, India. Indian Journal of Medical Research, 2008; 128: 38-44.


33.

Kumar T, Majumdar A, Das P, Sarafis V and Ghose M. Trypan blue as a fluorochrome for confocal laser scanning microscopy of arbuscular mycorrhizae in three mangroves. Biotechnic & Histochemistry, 2008; 83(3-4): 153-159.

32.

Pandey K, Sinha PK, Rabidas V, Kumar N, Bimal S, Verma N, Lal C and Das P. HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report. Cases Journal, 2008; 1: 183.


31.

Sahoo GC, Dikhit MR and Das P. Functional assignment to JEV proteins using SVM. Bioinformation, 2008; 3(1): 1–7.


30.

Narayan S, Gupta AK, Singh Subhankar K, Lal CS, Singh VP, Sinha PK, Das P and Thakur CP. Clinical and Laboratory comparision of different brands of Amphotericin B used for the treatment of kala-azar. Journal of Communicable Diseases, 2008; 40(4): 273-276.


29.

Muniaraj M, Dinesh DS, Sinha PK, Das P and Bhattacharya SK. Dual culture method to determine the relationship of gut bacteria of sandfly (Phlebotomus argentipes) with promastigotes of Leishmania donovani. J Commun Dis. 2008; 40(2): 133-138.

28.

Muniaraj M, Lal CS, Kumar S, Sinha PK and Das P. Milk of cow (Bos taurus), buffalo (Bubalus bubalis), and goat (Capra hircus): a better alternative than fetal bovine serum in media for primary isolation, in vitro cultivation, and maintenance of Leishmania donovani promastigotes. J. Clin. Microbiol,  2007; 45(4): 1353-1356.


27.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Verma N, Lal CS, Das P and Bhattacharya SK. Miltefosine in the Treatment of a case of Visceral Leishmaniasis with Renal Dysfunction. Ann Trop Med Parasitol, 2007; 101(7): 649-651.

26.

Sen A, Sekhar Chtterjee N, Ali Md A, Nandi N and Das P. The 29 Kilo-dalton Thiol-Dependent Peroxidase of Entamoeba histolytica Is a Factor Involved in Pathogenesis and Survival of the Parasite during Oxidative Stress Eukary. Eukaryot Cell, 2007; 6(4): 664–673.


25.

Lal CS, Kumar A, Kumar S, Pandey K, Kumar N, Bimal S, Sinha PK and Das P. Hypocholesterolemia and increased triglycerides in paediatric visceral leishmaniasis. Clinica Chimica Acta, 2007; 382(1-2): 151-153.


24.

Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg, 2007; 77(3): 560 – 561.

23.

Feng Y, Ortega Y, He G, Das P, Xu M, Zhang X, Fayer R, Gatei W, Cama V and Xiao L. Wide geographic distribution of Cryptosporidium bovis and the deer-like genotype in bovines. Vet Parasitol, 2007; 144(1-2): 1-9.


22.

Muniaraj M, Gupta AK, Narayan S, Singh D, Sinha PK, Das P. Long-term preservation of Leishmania donovani promastigotes on blood-agar slants, Ann Trop Med Parasitol. 2006; 100(2): 173-175.

21.

Das P, Roy SS, MitraDhar K, Dutta P, Bhattacharya MK, Sen A, Ganguly S, Bhattacharya SK, Lal AA and Xiao L. Molecular characterization of Cryptosporidium spp. from children in Kolkata, India. J. Clin. Microbiol. 2006; 44(11): 4246-4249.


20.

Das VN, Siddiqui NA, Kumar N, Verma N, Verma RB, Dinesh DS, Kar SK and Das P . A pilot study on the status of lymphatic filariasis in a rural community of Bihar. J Commun Dis, 2006; 38(2): 169-75.


19.

Bera T, Nandi N, Sudhahar D, Akbar MA, Sen A and Das P. Preliminary evidence on existence of transplasma membrane electron transport in Entamoeba histolytica trophozoites: a key mechanism for maintaining optimal redox balance. J Bioenerg Biomembr. 2006; 38(5-6): 299-308.


18.

Gatei W, Hart CA, Gilman RH, Das P, Cama V and Xiao L. Development of a multilocus sequence typing tool for Cryptosporidium hominis. J Eukaryot Microbiol, 2006; 53(Suppl1): S43-48.


17.

Kishore K, Kumar V, Kesari S, Dinesh DS, Kumar AJ, Das P and Bhattacharya SK. Vector control in leishmaniasis. Indian J Med Res, 2006; 123(3): 467-472.


16.

Pranati, Bimal S, Pandey K, Sinha PK, Gupta AK, Singh SK, Sundaram S and Das P. Leishmania donovani: Immunomodulatory Role of 63KDa Leishmania Antigen in the Promotion of IFN-gamma Response (VL vs HIV-VL Co-infection). American Journal of Immunology, 2006; 2(2): 52-57.

 

15.

Kumar V, Bimal S, Kesari S, Kumar AJ, Bagchi AK, Akbar MA, Kishore K, Bhattacharya SK and Das P. Evaluation of a dot-imunoblot assay for detecting leishmanial antigen in naturally infected Phlebotomus argentipes (Diptera: sychodidae). Ann Trop Med Parasitol. 2005; 99(4): 371-376.

14.

Bimal S, Das VN, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Sen A, Bhattacharya SK and Das P. Usefulness of the direct agglutination test in the early detection of subclinical L.  donovani infection: a community-based study. Ann Trop Med Parasitol, 2005; 99: 743-749.

13.

Bimal S, Singh SK, Das VN, Sinha PK, Gupta AK, Bhattacharya SK and Das P. Leishmania donovani: effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis. Exp Parasitol. 2005; 111(2): 130-132.

12.

Muniaraj M, Gupta AK, Narayan S, Kumar S, Sinha PK, Kishore K and Das P. Removal of bacterial and yeast contamination from Leishmania promastigote cultures, by agar plating. Ann Trop Med Parasitol. 2005; 99(6): 617-621.

11.

Muniaraj M, Gupta AK, Narayan S, Singh D, Sinha PK, Kishore K, Das P and Bhattacharya SK. Preservation of Leishmania donovani promastigotes in blood agar slants. Journal of communicable Diseases, 2005; 37(3): 191-195.

10.

Pandey K, Sinha PK, Das VN, Kumar N, Hassan SM, Verma N, Lal CS, Bimal S, Das P and Bhattacharya SK. HIV-I infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient- a case report. Ann Trop Med Parasitol, 2005; 99(8): 807-811.

9.

Dinesh DS, Kishore K, Das P and Bhattacharya, SK. Abnormality in Phlebotomus Argentipes (Diptera: Psychodidae). Current Science, 2005; 88(5): 703.

 

8.

Bimal S,  Singh S, Pandey K, Sinha PK, Das PK, Schallig H, Das P and Bhattacharya SK. Comparative evaluation of aqueous and freeze dried antigen for Sero-diagnosis of VL and PKDL cases by DAT. American Journal of Immunology, 2005; 1(2): 74-78.

 

7.

Singh SK, Bimal S, Dinesh DS, Gupta AK, Sinha PK, Bimal R and Das P. Towards identifying immunogenic targets in visceral leishmaniasis: role of 17 kDa and 63 kDa phosphoproteins. American Journal of Infectious Diseases, 2005; 1 (3): 94-98.

 

6.

Singh SK, Bimal S, Dinesh DS, Gupta AK, Sinha PK, Bimal R and Das P. Towards Identifying Immunogenic Targets in Visceral Leishmaniasis: Role of 17kDa and 63kDa Phosphoproteins. American Journal of Immunology, 2005; 1(3): 96-100.

 

5.

Kishore K, Kumar V, Kesari S, Bhattacharya SK and Das P. Susceptibility of Phlebotomus argentipes against DDT in endemic districts of North Bihar, India. The Journal of Communicable Diseases, 2004; 36(1): 41-44.

4.

Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, Ranjan A, Das P and Bhattacharya SK. Visceral Leishmaniasis and HIV Coinfection in Bihar, India. Letter to Editor, J Acquire Immune Defic Syndr. 2003; 32(1): 115-116.


3.

Sinha PK, Ranjan A, Siddique NA, Anil CK, Priya A, Das P and Bhattacharya SK. Usefulness of voluntary counseling and testing center for HIV/AIDS: Bihar as an example. J Acquir Immune Defic Syndr. 2003; 33(3): 407-408.


2.

Dasgupta B, Roychoudhury K, Ganguly S, Kumar Sinha P, Vimal S, Das P and Roy S.Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells. Ann Trop Med Parasitol. 2003; 97(3): 245-257.

1.

Kishore K, Kumar V, Lal CS, Kesari SK, Das P and Bhattacharya SK. Estimation of efficacy of malathion (SRES) against phlebotomus argentipes the vector of Indian kala-azar, with the help of bioassay and HPLC analysis. Journal of Tropical Medicine & Hygiene, 2002; 20: 13.